Leonard Kruimer
Chairman bij BIOINVENT INTERNATIONAL AB
Vermogen: 2 M $ op 31-03-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Alf Gunnar Martin Nicklasson | M | 69 | 11 jaar | |
| Adesh Kaul | M | 50 | 15 jaar | |
| Sijmen de Vries | M | 65 | 16 jaar | |
| Björn Frendéus | M | 51 | 23 jaar | |
| Martin Welschof | M | 63 | 6 jaar | |
| Domenico Scala | M | 59 | 13 jaar | |
| Adam Sinding Steensberg | M | 50 | 14 jaar | |
| Damian Heller | M | 58 | 9 jaar | |
| Peer Nils Schröder | M | - | - | |
| David Veitch | M | 59 | 10 jaar | |
| Thomas Werner | M | 68 | 13 jaar | |
| Ruud van Outersterp | M | 60 | 4 jaar | |
| Michael Levitan | M | 66 | - | |
| Bernadette Connaughton | F | 65 | 5 jaar | |
| Marc Engelhardt | M | 60 | 14 jaar | |
| Ivan M. Møller | M | 52 | 6 jaar | |
| Kristoffer Bissessar | M | 56 | 6 jaar | |
| Mireille Sanders | F | 56 | 5 jaar | |
| Frederik Barfoed Beck | M | 57 | - | |
| Anna Krassowska | F | - | - | |
| Jeffrey Berkowitz | M | 58 | 5 jaar | |
| Deborah Jorn | F | 66 | 5 jaar | |
| Vincent Ossipow | M | 55 | 8 jaar | |
| Cecilia Hofvander | F | - | 3 jaar | |
| Nicole Onetto | M | 71 | 7 jaar | |
| Kirsten Drejer | M | 68 | 6 jaar | |
| Stefan Ericsson | M | 61 | 26 jaar | |
| Laurenz Kellenberger | M | 57 | 24 jaar | |
| Anurag Relan | M | 52 | - | |
| Ingunn Munch Lindvig | M | - | 1 jaar | |
| Thomas Heineman | M | - | 4 jaar | |
| Stephen Toor | M | 52 | 4 jaar | |
| Christina Sonnenborg Bredal | F | 39 | 4 jaar | |
| Natalie Berner | F | 34 | 2 jaar | |
| Anneline Nansen | F | 55 | 3 jaar | |
| Marie Moores | F | - | 2 jaar | |
| Dung Tran Ngoc | F | - | - | |
| Henriette Wennicke | F | - | 2 jaar | |
| Martin Pålsson | M | 45 | 2 jaar | |
| Emma Meurling | F | - | - | |
| Ravinder Chahil | M | 56 | - | |
| Bernd Seizinger | M | 67 | 6 jaar | |
| Sylvie Ryckebusch | M | - | 2 jaar | |
| Gerrit Hauck | M | 60 | 6 jaar | |
| Jon Patton | M | - | 4 jaar | |
| Mark Pykett | M | 60 | 4 jaar | |
| Jeroen Wakkerman | M | 55 | 4 jaar | |
| Steven Baert | M | 50 | 3 jaar | |
| Carole A. Sable | M | 62 | 1 jaar | |
| Nanna Liebach Lüneborg | M | 49 | 2 jaar | |
| Alain Parthoens | M | 64 |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | 13 jaar |
| Andres McAllister | M | 68 | 7 jaar | |
| Barbara Yanni | F | 69 | 4 jaar | |
| Thomas O. Hecht | M | 73 | 4 jaar | |
| David M. Kendall | M | 62 | 2 jaar | |
| Erik Esveld | M | - | 3 jaar | |
| Kristoffer Rudenholm Hansson | M | 50 | 8 jaar | |
| Jabine T. M. van der Meijs | M | 58 | 3 jaar | |
| Richard Peters | M | 61 | 1 jaar | |
| Ursula Eberhardt | F | 62 | 18 jaar | |
| James Parsons | M | 58 | 2 jaar | |
| Elin Birgersson | F | 39 | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| René Beukema | M | 60 |
T.I.P. Europe Ltd.
 T.I.P. Europe Ltd. Other TransportationTransportation T.I.P. Europe Ltd. engaged in the operation of warehousing and storage facilities for land transport activities. The company was founded on March 26, 1986 and was headquartered in London, the United Kingdom.
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | 5 jaar |
| Paul Sekhri | M | 65 | 8 jaar | |
| Michael Oredsson | M | 64 | 5 jaar | |
| Arnold Hoevenaars | M | 74 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | - |
| Jane M. Birgitta Stymne Göransson | F | 67 | 2 jaar | |
| An van Es-Johansson | M | 64 | 5 jaar | |
| Aad de Winter | M | 71 | 12 jaar | |
| Mads Vindahl Kronborg | M | - | - | |
| Ulrika T. Mattson | F | 56 | 10 jaar | |
| Matthew D. Dallas | M | 49 | 3 jaar | |
| Rosemary Crane | F | 64 | 4 jaar | |
| Catherine Moukheibir | F | 64 | 5 jaar | |
| Alain Munoz | M | 75 | 17 jaar | |
| Cees de Jong | M | 63 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | - |
| William Rice | M | 65 | 6 jaar | |
| Michael Owen | M | 73 | 12 jaar | |
| Floris F. Waller | M | 66 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | 2 jaar |
| Emmanuel Dulac | M | 55 | 3 jaar | |
| Elin Jaensson Gyllenbäck | M | 45 | - | |
| Ronald H. P. Brus | M | 61 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | - |
| Ton Logtenberg | M | 65 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | 3 jaar |
| Domenico Valerio | M | 67 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | - |
| Lars Ingelmark | M | 75 | 12 jaar | |
| Lani Pollworth Morvan | M | - | 2 jaar | |
| Rie Schultz Hansen | M | - | 3 jaar | |
| John Barrie Ward | M | 86 | 14 jaar | |
| Steven Skolsky | M | 68 | 15 jaar | |
| Marie Paule Richard | M | 72 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | - |
| Robert Larry Anderson | M | 79 |
Pricewaterhouse & Co.
| 15 jaar |
| Jonathan Schatz | M | 67 |
Pricewaterhouse & Co.
| 13 jaar |
| Peter W. Schineller | M | 64 |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | 2 jaar |
| Jürgen Hermann Fechter | M | 61 |
Pricewaterhouse & Co.
| - |
| Arthur K. Lahr | M | 55 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | 10 jaar |
| Carolyn M. Kedersha | F | - |
Pricewaterhouse & Co.
| 3 jaar |
| Richard Elgin Rooney | M | - |
Pricewaterhouse & Co.
| 2 jaar |
| G. Edward Powell | M | 88 |
Pricewaterhouse & Co.
| 12 jaar |
| Iben Louise Gjelstrup | M | 47 | 4 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Nederland | 27 | 27.27% |
| Zweden | 26 | 26.26% |
| Denemarken | 23 | 23.23% |
| Zwitserland | 15 | 15.15% |
| Verenigde Staten | 6 | 6.06% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Leonard Kruimer
- Persoonlijk netwerk
